eBooks & Guides

The biologics researcher's guide to DLS

Issue link: https://resources.nanotempertech.com/i/1393304

Contents of this Issue

Navigation

Page 43 of 63

44 DLS data cannot inherently show you whether the change in r H is due to oligomerization or aggregation, but there are some general trends. For single protein species, which are generally in the high nm range for size (see Page 36), oligomerization events will not generally change the measured size by an order of magnitude or more. When you do see large jumps in size, for example from the 10 to 100 nm range, it's more likely to be amorphous aggregation. The broadening of size peaks likely indicates partial unfolding, which also increases the r H . For more in-depth assessment of what a change in PDI means you may want to also perform other techniques, particularly those that give information about turbidity and oligomerization mechanisms. On the other hand, if you know your particle should be behaving as a monodisperse, tightly folded species, formulation strategies such as buffer or additive screening can be applied to reduce the PDI and enhance the quality profile of your candidate (see Section 6, Table 2). It may also require an overhaul of the production or purification process.

Articles in this issue

view archives of eBooks & Guides - The biologics researcher's guide to DLS